Related references
Note: Only part of the references are listed.Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue respository of the Surveillance, Epidemiology, and End Results (SEER) program
W. F. Anderson et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Race modifies the association between breast carcinoma pathologic prognostic indicators and the positive status for HER-2/neu
AT Stark et al.
CANCER (2005)
Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer
HJ Huang et al.
ANNALS OF ONCOLOGY (2005)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer
HJ Huang et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related
HJ Huang et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Quantitative association between, HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer
G Konecny et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Real-world performance of HER2 testing - National surgical adjuvant breast and bowel project experience
S Paik et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Share Paper
